Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mertelsmann

Showing results (191-200 of 366) with videos related to

Pageof 37
Sort By:
Blood|November 15, 1990
Interleukin-6 (IL-6) is an intermediate in IL-1-induced proliferation of leukemic human megakaryoblastsM A Brach, B Löwenberg, L Mantovani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1983
Patients with secondary acute myelocytic leukemia (AML) receiving "timed" sequential chemotherapyZ A Arlin, S J Kempin, R Mertelsmann, et al.
Leukemia|December 1, 1993
N-RAS gene activation in acute myeloid leukemia: association with expression of interleukin-6M Lübbert, W Oster, H P Knopf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
Elevated circulating levels of tumor necrosis factor predict unresponsiveness to treatment with interferon alfa-2b in chronic myelogenous leukemiaF Herrmann, S G Helfrich, A Lindemann, et al.
Blood|February 1, 1994
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumorsW Brugger, K J Bross, M Glatt, et al.
Blood|September 1, 1994
Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicinW Brugger, R Henschler, S Heimfeld, et al.
British Journal of Haematology|September 1, 1990
Interleukin-4 regulates mRNA accumulation of macrophage-colony stimulating factor by fibroblasts: synergism with interleukin-1 betaR Henschler, L Mantovani, W Oster, et al.
Blood|August 1, 1984
Defective interleukin 2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin 2K Welte, N Ciobanu, M A Moore, et al.
Cancer|May 1, 1997
Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantationF C Dimeo, M H Tilmann, H Bertz, et al.
Journal of Biological Response Modifiers|October 1, 1990
Stimulation of granulopoiesis in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor: assessment of two routes of administrationF Herrmann, A Ganser, A Lindemann, et al.
Pageof 37

Showing results (191-200 of 366) with videos related to

Sort By:
Pageof 37
Blood|November 15, 1990
Interleukin-6 (IL-6) is an intermediate in IL-1-induced proliferation of leukemic human megakaryoblastsM A Brach, B Löwenberg, L Mantovani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1983
Patients with secondary acute myelocytic leukemia (AML) receiving "timed" sequential chemotherapyZ A Arlin, S J Kempin, R Mertelsmann, et al.
Leukemia|December 1, 1993
N-RAS gene activation in acute myeloid leukemia: association with expression of interleukin-6M Lübbert, W Oster, H P Knopf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
Elevated circulating levels of tumor necrosis factor predict unresponsiveness to treatment with interferon alfa-2b in chronic myelogenous leukemiaF Herrmann, S G Helfrich, A Lindemann, et al.
Blood|February 1, 1994
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumorsW Brugger, K J Bross, M Glatt, et al.
Blood|September 1, 1994
Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicinW Brugger, R Henschler, S Heimfeld, et al.
British Journal of Haematology|September 1, 1990
Interleukin-4 regulates mRNA accumulation of macrophage-colony stimulating factor by fibroblasts: synergism with interleukin-1 betaR Henschler, L Mantovani, W Oster, et al.
Blood|August 1, 1984
Defective interleukin 2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin 2K Welte, N Ciobanu, M A Moore, et al.
Cancer|May 1, 1997
Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantationF C Dimeo, M H Tilmann, H Bertz, et al.
Journal of Biological Response Modifiers|October 1, 1990
Stimulation of granulopoiesis in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor: assessment of two routes of administrationF Herrmann, A Ganser, A Lindemann, et al.
Pageof 37